VestGen Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VestGen Advisors's BMY Position: Q2 2026 in Review
VestGen Advisors reduced its Bristol-Myers Squibb (BMY) stake by 17% in Q2 2026, selling an estimated $351K and leaving 30,225 shares worth $1.74M. The position accounts for 0.05% of the portfolio, ranked #332.
VestGen Advisors first reported a position in BMY in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.05M in Q1 2026. 2,524 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- VestGen Advisors held 30,225 shares of Bristol-Myers Squibb worth $1.74M as of Q2 2026.
- VestGen Advisors sold 6,106 Bristol-Myers Squibb shares in Q2 2026, an estimated $351K.
- Bristol-Myers Squibb made up 0.05% of VestGen Advisors's portfolio in Q2 2026, its #332 holding.
- VestGen Advisors first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 6 quarters since.
- VestGen Advisors's Bristol-Myers Squibb position peaked at $2.05M in Q1 2026.
- 2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on VestGen Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.